About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in Phoenix | 110 Studies

Clinical Trials MigrainePhoenix

Migraine Clinical Trials in Phoenix

Find 110 clinical trials for migraine near Phoenix, Arizona. Connect with research centers in your area.

All Migraine trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 110 trials

Active not recruitingA Study to Evaluate White Matter Hyperintensities in MigraineThe purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migrainesNCT05112289·Phoenix, Arizona CompletedStudy to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionA study to evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days in participants with episodic migraine.NCT01952574·Phoenix, Arizona and 65 others

Migraine Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedSafety, Efficacy and Pharmacokinetics of ALD403The purpose of this study is to assess the safety, pharmacokinetics and efficacy of a single dose of ALD403 in the prevention of migraine headache in frequent episodic migraineurs…NCT01772524·Phoenix, Arizona and 25 others

CompletedEfficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineThe study is being conducted to evaluate two doses of TEV-48125 in adult patients with episodic migraineNCT02629861·Birmingham, Alabama and 274 others

CompletedeNeura SpringTMS Post-Market Observational US Study of MigraineA multi-center, prospective, non-randomized, single arm, open label, post-market, observational study to evaluate the use of the eneura, springtms system in reduction of migraine…NCT02357381·Phoenix, Arizona and 6 others

Active not recruitingA Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in AdultsThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing episodic migraine.NCT06047457·Birmingham, Alabama and 104 others

TerminatedGORE® CARDIOFORM Septal Occluder Migraine Clinical StudyMulti-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache reliefNCT04100135·Phoenix, Arizona and 14 others

RecruitingDetermining the Utility of a Behavioral Intervention in Chronic MigraineThis proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine.NCT05415020·Phoenix, Arizona

RecruitingA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual MigraineThe purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in…NCT06641466·Phoenix, Arizona and 122 others

CompletedThe Efficacy and Tolerability of NP101 Patch in the Treatment of Acute MigraineThis study was a randomized, parallel group, double-blind, placebo controlled design to compare the efficacy and tolerability of NP101 to a placebo iontophoretic transdermal patch.NCT00724815·Phoenix, Arizona and 33 others

WithdrawnStudy of Intravenous Erenumab in Patients With Status MigrainosusThe investigators will evaluate the efficacy for use of intravenous erenumab 140mg for treatment of status migrainosus in an open-label, pilot study.NCT04920331·Phoenix, Arizona

CompletedTreximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine AttacksThe purpose of this study is to determine the consistency of response for Treximet (sumatriptan/naproxen sodium), formerly known as Trexima, when treating four acute migraine…NCT00240630·Chandler, Arizona and 49 others

CompletedA 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine HeadachesThe purpose of this study is to evaluate the long-term safety of almotriptan malate (a migraine headache medication) in the treatment of migraine headaches in adolescents for up…NCT00257010·Mobile, Alabama and 48 others

RecruitingStudy to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to…NCT05125302·Huntsville, Alabama and 128 others

CompletedTREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)This study was designed to determine the efficacy and tolerability of TREXIMET (formerly known as TREXIMA) compared to placebo for the acute treatment of probable migraine, a…NCT00387881·Phoenix, Arizona and 69 others

CompletedStudy to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic MigraineThis study will evaluate safety and tolerability of treatment with atogepant for the prevention of episodic migraine over the course of one year.NCT03700320·Birmingham, Alabama and 111 others

CompletedMultimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)MOVEMENT (Multimechanistic Treatment over Time of Migraine Symptoms) is a Phase 3 study to evaluate the long-term safety of chronic intermittent use of AXS-07 and to assess the…NCT04068051·Birmingham, Alabama and 50 others

Completed12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic MigraineTo evaluate the safety and tolerability of atogepant 30 mg and 60 mg once a day for the prevention of migraine in participants with episodic migraine.NCT03777059·Chandler, Arizona and 137 others

CompletedEvaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough PainThe purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl for the potential treatment of breakthrough pain episodes in patients who have chronic…NCT00228605·Calera, Alabama and 37 others

CompletedEfficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of MigraineThis study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single migraine attack.NCT02867709·Birmingham, Alabama and 108 others

PreviousPage 4 of 6Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia